1. Pharmacists in oncology: Evidence still needed, but teaching comes first.
- Author
-
Van der Linden L and Van Aelst L
- Subjects
- Humans, Professional Role, Teaching standards, Teaching statistics & numerical data, Europe, Curriculum trends, Curriculum standards, Pharmacists, Education, Pharmacy methods, Education, Pharmacy trends, Education, Pharmacy standards, Medical Oncology education
- Abstract
Introduction: The pharmacy profession faces a lack of evidence pertaining to pharmaceutical care in oncology, both in terms of its effectiveness and its integration into clinical practice. While Europe-based pharmacists are active in many therapeutic areas, their role in cancer care is less defined. Conversely, the complexity of oncology, increasing cancer cases, and evolving therapies highlight the potential for pharmacists in this field. Their limited involvement in Europe may be attributed to inadequate undergraduate training and research., Perspective: Collaborative care shows potential in oncology, but still needs more trial evidence. Here, we can learn from pharmaceutical care in cardiology, where more research has been conducted. The limited role of pharmacists in oncology may be due to a lack of focus on oncology research and insufficient education., Implications: Addressing the teaching gap requires improving oncology education in pharmacy programs, at both undergraduate and postgraduate levels. Current postgraduate courses and US PharmD programs could serve as models. Equipping pharmacy students with fundamental oncology knowledge is a vital first step, for further meaningful research and practice. Formal education could bridge the gap between evidence and practice in these fields., Competing Interests: Declaration of competing interest The authors declare no conflicts of interest to disclose., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF